| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |